{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2025,12,30]],"date-time":"2025-12-30T08:58:39Z","timestamp":1767085119930},"reference-count":13,"publisher":"Springer Science and Business Media LLC","content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":[],"published-print":{"date-parts":[[2021,2,22]]},"DOI":"10.7759\/cureus.13486","type":"journal-article","created":{"date-parts":[[2021,2,22]],"date-time":"2021-02-22T14:11:44Z","timestamp":1614003104000},"source":"Crossref","is-referenced-by-count":4,"title":["A Possible Drug-Drug Interaction Between Eliquis and Amiodarone Resulting in Hemopericardium"],"prefix":"10.7759","author":[{"given":"Abdulbaril","family":"Olagunju","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Mohammad","family":"Khatib","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Frances","family":"Palermo-Alvarado","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"297","reference":[{"key":"ref1","doi-asserted-by":"publisher","DOI":"10.1161\/ATVBAHA.115.303397","article-title":"Overview of the new oral anticoagulants","volume":"35","author":"Yeh C","year":"2015","unstructured":"Yeh C, Hogg K, Weitz J. Overview of the new oral anticoagulants. Arterioscler Thromb Vasc Biol. 2015, 35:1056-65. 10.1161\/ATVBAHA.115.303397","journal-title":"Arterioscler Thromb Vasc Biol"},{"key":"ref2","doi-asserted-by":"publisher","DOI":"10.1056\/NEJMoa1107039","article-title":"Apixaban versus warfarin in patients with atrial fibrillation","volume":"365","author":"Granger C","year":"2011","unstructured":"Granger C, AlexanderJ, McMurray J, et al.. Apixaban versus warfarin in patients with atrial fibrillation. N Engl J Med. 2011, 365:981-92. 10.1056\/NEJMoa1107039","journal-title":"N Engl J Med"},{"key":"ref3","doi-asserted-by":"publisher","DOI":"10.1016\/j.hrcr.2017.11.015","article-title":"First reported case series in the United States of hemopericardium in patients on apixaban","volume":"4","author":"Sablani N","year":"2018","unstructured":"Sablani N, Garg J, Hasan B, Patel R, Martinez M. First reported case series in the United States of hemopericardium in patients on apixaban. HeartRhythm Case Rep. 2018, 4:82-4. 10.1016\/j.hrcr.2017.11.015","journal-title":"HeartRhythm Case Rep"},{"key":"ref4","doi-asserted-by":"crossref","unstructured":"A rare case of idiopathic hemorrhagic pericardial effusion presenting as cardiac tamponade. (2019). Accessed. October 18, 2020: https:\/\/doi.org\/10.1164\/ajrccm-conference.2019.199.1_MeetingAbstracts.A3534.","DOI":"10.1164\/ajrccm-conference.2019.199.1_MeetingAbstracts.A3534"},{"key":"ref5","doi-asserted-by":"publisher","DOI":"10.14740\/cr902","article-title":"Spontaneous hemorrhagic pericardial and pleural effusion in a patient receiving apixaban","volume":"10","author":"Cinelli M","year":"2019","unstructured":"Cinelli M, Uddin A, Duka I, Soomro A, Tamburrino F, Ghavami F, Lafferty J. Spontaneous hemorrhagic pericardial and pleural effusion in a patient receiving apixaban. Cardiol Res. 2019, 10:249-52. 10.14740\/cr902","journal-title":"Cardiol Res"},{"key":"ref6","doi-asserted-by":"publisher","DOI":"10.1007\/s40262-019-00775-z","article-title":"Apixaban: a clinical pharmacokinetic and pharmacodynamic review","volume":"58","author":"Byon W","year":"2019","unstructured":"Byon W, Garonzik S, Boyd R, Frost C. Apixaban: a clinical pharmacokinetic and pharmacodynamic review. Clin Pharmacokinet. 2019, 58:1265-79. 10.1007\/s40262-019-00775-z","journal-title":"Clin Pharmacokinet"},{"key":"ref7","doi-asserted-by":"publisher","DOI":"10.1177\/2042098617719815","article-title":"Potential drug-drug interactions with direct oral anticoagulants in elderly hospitalized patients","volume":"8","author":"Forbes H","year":"2017","unstructured":"Forbes H, Polasek T. Potential drug-drug interactions with direct oral anticoagulants in elderly hospitalized patients. Ther Adv Drug Saf. 2017, 8:319-28. 10.1177\/2042098617719815","journal-title":"Ther Adv Drug Saf"},{"key":"ref8","doi-asserted-by":"publisher","DOI":"10.1155\/2018\/1650716","article-title":"A rare case of spontaneous cardiac tamponade induced by concomitant use of rivaroxaban and amiodarone","volume":"2018","author":"Oladiran O","year":"2018","unstructured":"Oladiran O, Segal J, Nwosu I, Nazir S. A rare case of spontaneous cardiac tamponade induced by concomitant use of rivaroxaban and amiodarone. Case Rep Cardiol. 2018, 2018:1-4. 10.1155\/2018\/1650716","journal-title":"Case Rep Cardiol"},{"key":"ref9","doi-asserted-by":"publisher","DOI":"10.1016\/j.thromres.2020.08.016","article-title":"Drug-drug interactions with direct oral anticoagulants associated with adverse events in the real world: a systematic review","volume":"194","author":"Li A","year":"2020","unstructured":"Li A, Li M, Crowther M, Vazquez S. Drug-drug interactions with direct oral anticoagulants associated with adverse events in the real world: a systematic review. Thromb Res. 2020, 194:240-45. 10.1016\/j.thromres.2020.08.016","journal-title":"Thromb Res"},{"key":"ref10","doi-asserted-by":"publisher","DOI":"10.1002\/prp2.647","article-title":"Drug interactions with apixaban: a systematic review of the literature and an analysis of VigiBase, the World Health Organization database of spontaneous safety reports","volume":"8","author":"Fernandez S","year":"2020","unstructured":"Fernandez S, Lenoir C, Samer C, Rollason V. Drug interactions with apixaban: a systematic review of the literature and an analysis of VigiBase, the World Health Organization database of spontaneous safety reports. Pharmacol Res Perspect. 2020, 8:00647. 10.1002\/prp2.647","journal-title":"Pharmacol Res Perspect"},{"key":"ref11","doi-asserted-by":"publisher","DOI":"10.1182\/hem.V15.2.8269","article-title":"Physicians beware: direct oral anticoagulants do interact with some commonly used drugs","volume":"15","author":"Linkins L","year":"2018","unstructured":"Linkins L. Physicians beware: direct oral anticoagulants do interact with some commonly used drugs. Hematologist. 2018, 15:1. 10.1182\/hem.V15.2.8269","journal-title":"Hematologist"},{"key":"ref12","doi-asserted-by":"publisher","DOI":"10.1016\/j.jacc.2014.07.967","article-title":"Amiodarone, anticoagulation, and clinical events in patients with atrial fibrillation: insights from the ARISTOTLE trial","volume":"64","author":"Flaker G","year":"2014","unstructured":"Flaker G, Lopes D, Hylek E, et al.. Amiodarone, anticoagulation, and clinical events in patients with atrial fibrillation: insights from the ARISTOTLE trial. J AM Coll Cardiol. 2014, 64:1541-50. 10.1016\/j.jacc.2014.07.967","journal-title":"J AM Coll Cardiol"},{"key":"ref13","article-title":"Apixaban (eliquis) for stroke prevention in atrial fibrillation","volume":"89","author":"Beck R","year":"2014","unstructured":"Beck R, King W. Apixaban (eliquis) for stroke prevention in atrial fibrillation. Am Fam Physician. 2014, 89:672-75.","journal-title":"Am Fam Physician"}],"container-title":["Cureus"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/www.cureus.com\/articles\/51575-a-possible-drug-drug-interaction-between-eliquis-and-amiodarone-resulting-in-hemopericardium","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2024,2,9]],"date-time":"2024-02-09T19:34:07Z","timestamp":1707507247000},"score":1,"resource":{"primary":{"URL":"https:\/\/www.cureus.com\/articles\/51575-a-possible-drug-drug-interaction-between-eliquis-and-amiodarone-resulting-in-hemopericardium"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2021,2,22]]},"references-count":13,"URL":"https:\/\/doi.org\/10.7759\/cureus.13486","relation":{},"ISSN":["2168-8184"],"issn-type":[{"value":"2168-8184","type":"print"}],"subject":[],"published":{"date-parts":[[2021,2,22]]}}}